Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042373 (vascular disease)
 17,070 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The author reviews the pertinent literature and the results of own investigations in migraine. EEG changes in migraine are observed in nearly 50% of cases during attacks as well as in the periods free of pains. Most investigations were done in the periods between attacks. The H response characteristic of migraine was found by the author in 25% of cases only. Focal changes were present in 30% of cases. They were not related to the side of the pain, its duration and the form of migraine. Seizure activity was never observed. The author regards isolation of the so-called dysrhythmic form of migraine as not justified. EEG changes suggest--according to the author--that migraine is a primary cerebral and only secondarily a vascular disorder.
Neurol Neurochir Pol
PMID:[Electroencephalographic studies in migraine]. 115 64

In 40 patients with diabetes mellitus type II without clinical signs of any organ complications and in the respective control group the following indices of hemostasis were assessed: 1) activity of AI-III, 2) activity of alfa-2-AP, 3) fibrinogen, 4) time of fibrinolysis, 5) platelets count, adhesiveness and spontaneous aggregation, 6) kaolin-cephalin and profil stipven-cephalin plasma times. All these indices were normal in uncomplicated diabetes mellitus with the expectation of platelets activity. Stimulation of platelets activity and increase of corresponding parameters appears in diabetes mellitus type II before any other symptoms of angiopathy.
Pol Tyg Lek
PMID:[Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2]. 140 34

Alzheimer's disease (AD), the most common presenile dementia is underdiagnosed in Poland, thus every attempt to make the frequency of this diagnosis approaching standards of Western countries should be recommended. Deposits of beta A4 amyloid in a form of amyloid (senile) plaques, diffuse amyloid deposits and congophilic angiopathy is central to the pathogenesis of AD. These amyloid deposits are virtually invisible in routine pathological stainings like HE but may be visualized with Bielschowsky silver impregnation, other metallic impregnations, and following Thioflavine S or Congo red stainings. We report here that amyloid deposits are as easily immunolabeled with commercially available antibodies against beta A4 (DAKO) and such a staining was greatly enhanced by microwave oven pretreatment. In all cases of AD, the diagnosis could be easily made using either 4GM or commercial DAKO anti-beta A4 antibodies following pretreatment with formic acid or processing in microwave oven. Pretreatment in microwave oven even for only one second was already sufficient to visualize beta A4-immunopositive plaques while after 5 second the intensity of staining approached that obtained after formic acid pretreatment.
Pol J Pathol 1995
PMID:Diagnosis of Alzheimer's disease with commercially available anti-beta peptide (beta A4) antibodies following microwave oven pretreatment. 778 Jun 97

In 34 cases of ischaemic cerebral vascular disease (24 patients with completed stroke and 10 with RIND or TIA) complex studies of serum lipids were performed. The level of total cholesterol, cholesterol HDL, phospholipids, triglycerides and apolipoprotein B was evaluated. The obtained results revealed in RIND and TIA syndrome higher values of phospholipids, apolipoprotein B and cholesterol HDL than in completed ischaemic stroke. However the differences were not great enough, draw conclusions about the dynamics of changes in course of progress of the ischaemic cerebral vascular disease. In allmost all cases of completed stroke and in RIND or TIA syndrome a drop of cholesterol HDL was found. Other deviations of lipid level were noticed only in few cases. Notwithstanding the significance of other than hyperlipidemia risk factors, especially of elevated blood pressure, it seems reasonable to start adequate treatment when in patient with RIND or TIA abnormal values of serum lipids are found.
Neurol Neurochir Pol
PMID:[Patterns of lipid change in serum as a risk factor for ischemic brain disease]. 811 88

During diabetic process angiopathy of lung vessels may be expected. In the study authors evaluated values of spirometric and gasometric parameters in patients with diabetes mellitus in two groups--with and without diabetic complications. It was documented that diabetic process caused the decrease of pulmonary diffusion volume and some gasometric disturbances. This above mentioned spirometric and gasometric changes indicated some coexistence with a late diabetic complications.
Pneumonol Alergol Pol 1993
PMID:[Pulmonary function changes as a late diabetic complications]. 836 32

In 30 patients with diabetes type II and macroangiopathy of lower extremities, physical training was applied. This treatment was carried on in our Clinic for average 4 weeks. The following methods were applied: individual exercises of legs once or twice daily for 30-minutes, training in brine swimming pool for 30 minutes every-day, treatment walks with proportioning effort. Value of physical effort was not more than 30-40% max. pulse rate. The examination was performed before and after the programme of treatment. The examination included the following parameters: subjective test on cycloergometer, examination of blood flow velocity by Doppler method and biochemical examination of glycaemia and lipidemia. We found improvement in intermittent claudication distance, significant subjective improvement in velocity of blood flow in lower extremities. In our opinion physical vascular training is a valuable method of mono-operative treatment of vascular disease of legs in diabetic patients.
Pol Tyg Lek 1996 Jan
PMID:[Results of kinesis therapy in patients with diabetic macroangiopathy of the lower extremities]. 875 93

Microalbuminuria and its associations with vascular disease has been reported in diabetic and non-diabetic individuals. The significance of microalbuminuria in cardiovascular complications is unclear. It has been suggested that microalbuminuria reflects a more generalized pathological process of the vascular system, affecting the glomeruli, retinal vessels and the intimal larger vessels, simultaneously. Microalbuminuria is more prevalent in diabetic, hypertensive and elderly people with risk of vascular complications. Testing for microalbuminuria is recommended for all identifying subgroups with risk vascular complications and premature death. Such program is likely to be cost-effective because of savings in the treatment costs and complications (e.g. renal dialysis and transplantation).
Pol Merkur Lekarski 1997 Jul
PMID:[Microalbuminuria as a prognostic marker of cardiovascular diseases]. 943 97

Hypertension is an important risk factor for vascular disease. Primary goal of hypertension treatment is to prevent or delay the onset of blood pressure-related morbidity and mortality. It has been well demonstrated that the responses rate to any single class of antihypertensive agent, give as monotherapy is approximately 45% to 55%, and in half of hypertensive population a second will be required. The data from clinical trials clearly demonstrate that two-drug combination, usually with low-dose diuretics with any one of the other first-line agents increases the response rate to about 80% to 85% and reduces the likelihood of adverse events and alteration in lipid, carbohydrate and electrolyte metabolism. Of the various combinations being given that of an diuretic and ACE inhibitor, and ACE inhibitor and non-dihydropyridine calcium channel blockers seems particularly attractive. Some combinations are inappropriate, such as diuretic and calcium channel blockers, and beta-blocker with verapamil and diltiazem. Combination of ACE inhibitor and a non-dihydropyridine calcium channel blockers may provide benefit in regression left ventricular hypertrophy diabetic nephropathy, and post myocardial infarction.
Pol Merkur Lekarski 1998 Jan
PMID:[Combination therapy in primary hypertension]. 955 8

In this report we assess the systolic maximal flow velocity in carotid and intracranial arteries in 191 subjects with no history of cerebral vascular disease in 3 age groups: 20-40 years (1 group), 41-60 years (2 group), and above 60 years (3 group). The subjects were assessed using Sonomed Transcranial Doppler Spectrograph according to generally accepted principles. The purpose of the study was to establish the mean value of maximal flow velocity in each particular artery in three age groups, and to observe the changes in this parameter with age. The results were analyzed using statistical methods and a significant decrease in blood flow, Vmax, was found in all investigated arteries. A mean decrease of 8.02% in flow velocity Vmax was found, when comparing groups 2 and 1, and difference 15.99% comparing 3 and 1.
Neurol Neurochir Pol
PMID:[The assessment of flow velocity in carotid and intracranial arteries in three different age groups]. 977 Jun 88

The aim of our study was to estimate selected parameters of hemostasis and fibrinolysis in diabetic patients with vascular complications and obesity. The investigation was carried out in 23 type 1 diabetic subjects aged 17-56 ys, in 25 type 2 diabetic patients aged 41-69 ys and in 38 healthy persons: 16 "young"--aged 32.5 +/- 13.2 ys and 22 "old"--aged 56.2 +/- 9.4 ys. The following parameters were determined: glycaemia, HbA1c, blood level fibrinogen, euglobulin clot lysis time, plasminogen activator inhibitor (PAI-1) activity, microalbuminuria, triglyceride, total, HDL- and LDL-cholesterol concentration. Plasma fibrinogen level was elevated in type 2 diabetic subjects, and the highest concentrations were noted in patients with retinopathy or arterial hypertension, in overweight persons and--surprisingly--in type 1 diabetic subjects with nephropathy and coronary vascular disease (CVD). There were also positive correlations between fibrinogen level and systolic blood pressure (r = 0.3413, p < 0.02), diastolic blood pressure (r = 0.3809, p < 0.002) and microalbuminuria (r = 0.3552, p < 0.05). The mean euglobulin clot lysis time was prolonged in type II diabetics in comparison to the control group, especially in obese subjects. The highest activity of PAI-1 was found in overweight controls (28.87 +/- 6.24 Au/ml, p < 0.002). PAI-1 activity was also slightly increased in type 1 diabetic patients, especially with the symptoms of diabetic neuropathy, nephropathy or CHD, in comparison to the other groups. Our results seem to confirm the disturbed balance between coagulation and fibrinolysis--towards and increased risk of a prothrombotic state --in both--obese and diabetic patients--especially with advanced vascular complications.
Pol Arch Med Wewn 1998 Aug
PMID:[Some parameters of hemostasis and fibrinolysis in diabetic patients]. 1010 28


1 2 3 4 5 Next >>